RENADAPTOR
LA JUSTE PRESCRIPTION POUR L'INSUFFISANCE RENALE ET LA DIALYSE
RENADAPTOR
DAS RICHTIGE REZEPT FÜR NIERENVERSAGEN UND DIALYSE
LA JUSTE PRESCRIPTION POUR L'INSUFFISANCE RENALE ET LA DIALYSE
DAS RICHTIGE REZEPT FÜR NIERENVERSAGEN UND DIALYSE
14/03/2024 : 10ième symposium "Reins & Médicament" du CHR de Liège
Click here17/03/2023 : Contrat d'intégration de RenAdaptor dans la base de données POSOS - France;
Click here09/03/2023 : 9ième symposium "Reins & Médicament" du CHR de Liège
Click here22/12/2022 : Signature d'un contrat exclusif de distribution avec la société Axilios
Click here10/03/2022 : 8ième symposium "Reins & Médicament" du CHR de Liège
Click here18/04/2021 : Creation of a new feature "Create a list" which now allows you to store a created list of medications.
12/03/2021 : Creation of a direct reference link to the PubMed directory for abstract reading.
31/10/2019 : First integrated version of Renadaptor in DelphiCare of the belgian pharmaceutical association (APB)
Click here24/09/2019 : First institutional version of www.renadaptor.org proposed at the hospital CHR of Liège - Belgium
14/03/2019 : 7ième symposium "Reins & Médicament" du CHR de Liège
Click here
30/03/2024 : Sotatercept
Click here
25/03/2024 : Givinostat
Click here
20/03/2024 : Aprocitentan
Click here
17/03/2024 : Resmetirom
Click here
12/03/2024 : Exagamglogene autotemcel
Click here
24/02/2024 : Cefepime + Enmetazobactam
Click here
30/01/2024 : Gadopiclenol
Click here
31/12/2023 : Palopegteriparatide
Click here
31/12/2023 : Pegzilarginase
Click here
30/12/2023 : Tabelecleucel
Click here
23/12/2023 : Eplontersen
Click here
09/12/2023 : Iptacopan
Click here
29/11/2023 : Nirogacestat
Click here
25/11/2023 : Lebrikizumab
Click here
22/11/2023 : Efbemalenograstim
Click here
21/11/2023 : Capivasertib
Click here
17/11/2023 : Repotrectinib
Click here
10/11/2023 : Fruquintinib
Click here
30/10/2023 : Toripalimab
Click here
27/10/2023 : Etrasimod
Click here
27/10/2023 : Vamorolone
Click here
21/10/2023 : Gefapixant
Click here
21/10/2023 : Zilucoplan
Click here
21/10/2023 : Itopride
Click here
16/10/2023 : Tislelizumab
Click here
07/10/2023 : Nedosiran
Click here
07/10/2023 : Gepirone
Click here
06/10/2023 : Motixafortide
Click here
22/09/2023 : Momelotinib
Click here
23/08/2023 : Avacincaptad pegol
Click here
23/08/2023 : Pegcetacoplan
Click here
22/08/2023 : Vadadustat
Click here
21/08/2023 : Pozelimab
Click here
21/08/2023 : Palovarotene
Click here
20/08/2023 : Elranatamab
Click here
19/08/2023 : Cipaglucosidase alfa
Click here
19/08/2023 : Miglustat
Click here
19/08/2023 : Levoketoconazole
Click here
17/08/2023 : Mirikizumab
Click here
13/08/2023 : Talquetamab
Click here
12/08/2023 : Zuranolone
Click here
24/07/2023 : Quizartinib
Click here
18/07/2023 : Glofitamab
Click here
15/07/2023 : Brolucizumab
Click here Click here
15/07/2023 : Faricimab
Click here Click here
05/07/2023 : Ranibizumab
Click here Click here
01/07/2023 : Rozanolixizumab
Click here
29/06/2023 : Ritlecitinib
Click here
25/06/2023 : Eflapegrastim
Click here
25/06/2023 : Sulbactam + Durlobactam
Click here
24/06/2023 : Pegunigalsidase alfa
Click here
24/06/2023 : Efgartigimod alfa + Hyaluronidase
Click here
22/05/2023 : Epcoritamab
Click here
20/05/2023 : Fezolinetant
Click here
27/04/2023 : Tofersen
Click here
18/04/2023 : Omidubicel
Click here
16/04/2023 : Rezafungin
Click here
10/04/2023 : Vilobelimab
Click here
30/03/2023 : Etranacogene dezaparvovec
Click here
25/03/2023 : Leniolisib
Click here
25/03/2023 : Retifanlimab
Click here
24/03/2023 : Trofinetide
Click here
14/03/2023 : Zavegepant
Click here
02/03/2023 : Omaveloxolone
Click here
23/02/2023 : Sparsentan
Click here
03/02/2023 : Daprodustat
Click here
30/01/2023 : Isoflurane
Click here Click here
28/01/2023 : Elacestrant
Click here
28/01/2023 : Pirtobrutinib
Click here
28/01/2023 : Bexagliflozin
Click here
28/01/2023 : Desflurane
Click here Click here
22/01/2023 : MEOPA / Nitrous oxide
Click here Click here
22/01/2023 : Sevoflurane
Click here Click here
08/01/2023 : Lecanumab
Click here
30/12/2022 : Ublituximab
Click here
30/12/2022 : Octreotide acetate (oral)
Click here
27/12/2022 : Fecal microbiota
Click here
13/12/2022 : Adagrasib
Click here
04/12/2022 : Olutasidenib
Click here
27/11/2022 : Sincalide
Click here
21/11/2022 : Teplizumab
Click here
19/11/2022 : Mirvetuximab soravtansine
Click here
28/10/2022 : Teclistamab
Click here
27/10/2022 : Tremelimumab
Click here
14/10/2022 : Futibatinib
Click here
14/10/2022 : Deucravacitinib
Click here
30/09/2022 : Phenylbutyrate Na + Taurursodiol
Click here
29/08/2022 : Lenacapavir
Click here
17/08/2022 : Eladocagene exuparvovec
Click here
02/08/2022 : Olipudase alfa
Click here
02/08/2022 : Atidarsagene autotemcel
Click here
12/07/2022 : Indigotindisulfonate Na
Click here
12/07/2022 : Linzagolix
Click here
11/07/2022 : Mosunetuzumab
Click here
17/06/2022 : Ciltacabtagene autoleucel
Click here Click here
16/06/2022 : Vutrisiran
Click here
17/05/2022 : Vonoprazan
Click here
14/05/2022 : Roxadustat
Click here
14/05/2022 : Tirzepatide
Click here
01/05/2022 : Trientine 4HCl
Click here
01/05/2022 : Mavacamten
Click here
01/05/2022 : Oteseconazole
Click here
02/04/2022 : Lutetium Lu 177 vipivotide tetraxetan
Click here
22/03/2022 : Nivolumab + Relatlimab
Click here
20/03/2022 : Ganaxolone
Click here
20/03/2022 : Somatrogon
Click here
Click here
08/03/2022 : Pacritinib
Click here
18/02/2022 : Mitapivat
Click here
16/02/2022 : Bebtelovimab
Click here
16/02/2022 : Tixagevimab + Cilgavimab
Click here
16/02/2022 : Bamlanivimab + Etesevimab
Click here
15/02/2022 : Molnupiravir
Click here
14/02/2022 : Casirivimab + Imdevimab
Click here
Click here
14/02/2022 : Regdanvimab
Click here
14/02/2022 : Nirmatrelvir + Ritonavir
Click here
Click here
05/02/2022 : Sutimlimab
Click here
28/01/2022 : Tebentafusp
Click here
22/01/2022 : Abrocitinib
Click here
21/01/2022 : Sotrovimab
Click here
12/01/2022 : Daridorexant
Click here
23/12/2021 : Efgartigimod alfa
Click here
23/12/2021 : Tezepelumab
Click here
18/12/2021 : Budesonide delayed release
Click here
03/12/2021 : Pafolacianine
Click here
27/11/2021 : Maribavir
Click here
24/11/2021 : Nab-sirolimus
Click here
22/11/2021 : Vosoritide
Click here
06/11/2021 : Avacopan
Click here
31/10/2021 : Asciminib
Click here
18/10/2021 : Maralixibat
Click here
14/10/2021 : Atogepant
Click here
29/09/2021 : Tisotumab vedotin
Click here
19/09/2021 : Mobocertinib
Click here
31/08/2021 : Difelikefalin
Click here
29/08/2021 : Lonapegsomatropine
Click here
27/08/2021 : Bimekizumab
Click here
19/08/2021 : Belzutifan
Click here
19/08/2021 : Elivaldogene autotemcel
Click here
18/08/2021 : Avalglucosidase alfa
Click here
03/08/2021 : Anifrolumab
Click here
27/07/2021 : Odevixibat
Click here
26/07/2021 : Tralokinumab
Click here
17/07/2021 : Belumosudil
Click here
14/07/2021 : Idecabtagene vicleucel
Click here
14/07/2021 : Brincidofovir
Click here
13/07/2021 : Finerenone
Click here
13/07/2021 : Fosdenopterin
Click here
12/07/2021 : Ibrexafungerp
Click here
12/07/2021 : Olanzapine + Samidorphan
Click here
08/06/2021 : Aducanumab
Click here
31/05/2021 : Sotorasib
Click here
31/05/2021 : Infigratinib
Click here
29/05/2021 : Relugolix + Estradiol + Norethisterone / Norethindrone
Click here
26/05/2021 : Amivantamab
Click here
18/05/2021 : Pegcetacoplan
Click here
07/05/2021 : Citrate K + Bicarbonate K
Click here
28/04/2021 : Loncastuximab tesirine
Click here
25/04/2021 : Dostarlimab
Click here Click here
18/04/2021 : Estetrol + Drospirenone
Click here Click here
05/04/2021 : Viloxazine ER
Click here
27/03/2021 : Dasiglucagon
Click here
25/03/2021 : Ponesimod
Click here
14/03/2021 : Melphalan flufenamide
Click here
06/03/2021 : Brexucabtagene autoleucel
Click here
Click here
06/03/2021 : Casimersen
Click here
05/03/2021 : Serdexmethylphenidate + Dexmethylphenidate
Click here
26/02/2021 : Lisocabtagene maraleucel
Click here
20/02/2021 : Trilaciclib
Click here
19/02/2021 : Evinacumab
Click here
12/02/2021 : Umbralisib
Click here
12/02/2021 : Tepotinib
Click here
30/01/2021 : Voclosporin
Click here
29/01/2021 : Cabotegravir
Click here
29/01/2021 : Rilpivirine IM
Click here
25/01/2021 : Inclisiran
Click here
24/01/2021 : Vericiguat
Click here
24/01/2021 : Berotralstat
Click here
24/01/2021 : Ansuvimab
Click here
24/01/2021 : Margetuximab
Click here
28/12/2020 : Vibegron
Click here
19/12/2020 : Relugolix
Click here
07/12/2020 : Setmelanotide
Click here
02/12/2020 : Lumasiran
Click here
29/11/2020 : Naxitamab
Click here
28/11/2020 : Lonafarnib
Click here
18/11/2020 : Filgotinib
Click here
18/11/2020 : Imlifidase
Click here
17/10/2020 : Atoltivimab + Maftivimab + Odesivimab
Click here
07/09/2020 : Somapacitan
Click here
18/08/2020 : Satralizumab
Click here
14/08/2020 : Bulevirtide
Click here
14/08/2020 : Viltolarsen
Click here
12/08/2020 : Risdiplam
Click here
12/08/2020 : Oliceridine
Click here
12/08/2020 : Belantamab mafodotin
Click here
11/08/2020 : Tafasitamab
Click here
21/07/2020 : Decitabine + Cedazuridine
Click here
21/07/2020 : Betibeglogene autotemcel
Click here
08/07/2020 : Remdesivir
Click here
06/07/2020 : Fostemsavir
Click here
04/07/2020 : Remimazolam
Click here
30/06/2020 : Fenfluramine
Click here
23/06/2020 : Lurbinectedin
Click here
22/06/2020 : Inebilizumab
Click here
10/06/2020 : Onasemnogene abeparvovec
Click here
Click here
27/05/2020 : Daratumumab + Hyaluronidase
Click here
19/05/2020 : Ripretinib
Click here
13/05/2020 : Selpercatinib
Click here
09/05/2020 : Capmatinib
Click here
01/05/2020 : Monomethyl fumarate
Click here
30/04/2020 : Sacituzumab Govitecan
Click here
22/04/2020 : Pemigatinib
Click here
21/04/2020 : Tucatinib
Click here
14/04/2020 : Selumetinib
Click here
01/04/2020 : Ferric pyrophosphate citrate
Click here
29/03/2020 : Ozanimod
Click here
04/03/2020 : Osilodrostat
Click here
03/03/2020 : Isatuximab
Click here
02/03/2020 : Eptinezumab
Click here
02/03/2020 : Rimegepant
Click here
26/02/2020 : Bempedoic acid
Click here
27/01/2020 : Tazemetostat
Click here
23/01/2020 : Teprotumumab
Click here
13/01/2020 : Avapritinib
Click here
27/12/2019 : Lumateperone
Click here
27/12/2019 : Lemborexant
Click here
26/12/2019 : Enfortumab vedotin
Click here
24/12/2019 : Trastuzumab Deruxtecan
Click here
24/12/2019 : Ubrogepant
Click here
24/12/2019 : Levamlodipine
Click here
16/12/2019 : Golodirsen
Click here
26/11/2019 : Voxelotor
Click here
25/11/2019 : Cenobamate
Click here
21/11/2019 : Givosiran
Click here
18/11/2019 : Crizanlizumab
Click here
18/11/2019 : Cefiderocol
Click here
15/11/2019 : Zanubrutinib
Click here
11/11/2019 : Luspatercept
Click here
03/11/2019 : Diroximel fumarate
Click here
23/10/2019 : Elexacaftor + Tezacaftor + Ivacaftor
Click here
18/10/2019 : Lasmiditan
Click here
13/10/2019 : Levodopa (inhalation)
Click here
Click here
23/09/2019 : Semaglutide (oral)
Click here
07/09/2019 : Istradefylline
Click here
05/09/2019 : Lefamulin
Click here
04/09/2019 : Fedratinib
Click here
30/08/2019 : Entrectinib
Click here
29/08/2019 : Pretomanid
Click here
28/08/2019 : Upadacitinib
Click here
13/08/2019 : L-Arginine + L-Lysine
Click here
05/08/2019 : Pexidartinib
Click here
01/08/2019 : Darolutamide
Click here
19/07/2019 : imipenem + cilastatin + relebactam
Click here
19/07/2019 : Pentosan polysulfate sodium
Click here
Click here
05/07/2019 : Selinexor
Click here
24/06/2019 : Zanamivir IV
Click here
24/06/2019 : Bremelanotide
Click here
23/06/2019 : Polatuzumab vedotin
Click here
21/06/2019 : Ropeginterferon alfa-2b
Click here
21/06/2019 : Volanesorsen
Click here
21/06/2019 : Sotagliflozin
Click here
26/05/2019 : Alpelisib
Click here
29/04/2019 : Risankizumab
Click here
14/04/2019 : Erdafitinib
Click here
12/04/2019 : Romosozumab
Click here
29/03/2019 : Solriamfetol
Click here
29/03/2019 : Siponimod
Click here
28/03/2019 : Phendimetrazine tartrate
Click here
28/03/2019 : Testosterone undecanoate
Click here
23/03/2019 : Brexanolone
Click here
22/03/2019 : Curcuma longa
Click here
23/03/2019 : Macimorelin
Click here
20/03/2019 : Fexinidazole
Click here
15/03/2019 : Esketamine
Click here
05/03/2019 : Trastuzumab hyaluronidase
Click here
27/02/2019 :Turoctocog alfa pegol
Click here
Renal drug dosage adjustments and adverse drug events in patients with chronic kidney disease admitted to the hospital: a cross-sectional study.
Očovská Z, et al. Expert Opin Drug Saf. 2024 Feb 8.
Click here
Glomerular hyperfiltration as a therapeutic target for CKD.
Kanbay M, et al. NDT 2024 Feb 02.
Click here
Toxic Nephropathies of the Tubulointerstitium: Core Curriculum 2024.
Krishnan N, et al. AJKD 2024 Jan 19.
Click here
Advances in the management of chronic kidney disease.
Chen TK, et al. BMJ. 2023 Dec 05.
Click here
Drugs with a negative impact on cognitive function (Part 1): chronic kidney disease as a risk factor.
Liabeuf S, et al. CKJ. 2023 Dec.
Click here
Drugs with a negative impact on cognitive functions (Part 2): drug classes to consider while prescribing in CKD patients.
Hafez G, et al. CKJ. 2023 Dec.
Click here
Antiobesity Pharmacotherapy in Adults with Chronic Kidney Disease.
Taber-Hight E, et al. Kidney Int. 2023 Nov 03.
Click here
Kidney Stone Pathophysiology, Evaluation and Management: Core Curriculum 2023
Shastri S, et al. AJKD 2023 Aug 09.
Click here
Balanced crystalloid solution versus saline in deceased donor kidney transplantation (BEST-Fluids): a pragmatic, double-blind, randomised, controlled trial.
Collins MG, et al. Lancet 2023 Jun 16.
Click here
Atrial Fibrillation in Kidney Failure: Challenges in Risk Assessment and Anticoagulation Management
Law MM, et al. Kidney Med. 2023 Jun 19.
Click here
Combination Diuretic Therapy to Counter Renal Sodium Avidity in Acute Heart Failure: Trials and Tribulations.
Kazory A. CJASN 2023 Apr 27.
Click here
Hydrochlorothiazide and Prevention of Kidney-Stone Recurrence.
Dhayat NA, et al. NEJM 2023 Mar 02.
Click here
Cystatin C–Based Equation to Estimate GFR without the Inclusion of Race and Sex.
Hans Pottel et al. NEJM 2023 Jan 26.
Click here
Prise en charge de la carence martiale au cours de la maladie rénale chronique : mise au point et proposition d'un algorithme [Management of iron deficiency in chronic kidney disease: Review and proposed algorithm].
Guibergia C, et al. Nephrol Ther. 2022 Dec.
Click here
Empagliflozin in Patients with Chronic Kidney Disease.
The EMPA-KIDNEY Collaborative Group. NEJM Nov 04.
Click here
Renin–Angiotensin System Inhibition in Advanced Chronic Kidney Disease
Bhandari S, et al. NEJM Nov 03.
Click here
Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO).
de Boer IH, et al. Kidney Int. 2022 Sep.
Click here
Use of Glucose-Lowering Agents in Diabetes and Chronic Kidney Disease.
Alicic RZ, et al. KIRep. 2022 Sep.
Click here
Acetazolamide in Acute Decompensated Heart Failure with Volume Overload.
Mullens W, et al. NEJM 2022 Aug.
Click here
Antifibrotic Agents for the Management of CKD: A Review.
Ruiz-Ortega M, et al. AJKD. 2022 Aug.
Click here
Management of Metabolic Acidosis in Chronic Kidney Disease: Past, Present, and Future Direction
Goraya N, et al. ACKD 2022 Jul.
Click here
European Renal Best Practice endorsement of guidelines for diagnosis and therapy of thrombotic thrombocytopaenic purpura published by the International Society on Thrombosis and Haemostasis.
Eller K, et al. NDT. 2022 Jul.
Click here
Management of Diabetes Mellitus in Patients With CKD: Core Curriculum 2022.
Hahr AJ, et al. AJKD. 2022 May.
Click here
Interventions To Attenuate Vascular Calcification Progression in Chronic Kidney Disease: A Systematic Review of Clinical Trials.
Xu C, et al. JASN 2022 May.
Click here
Gliflozins in the Management of Cardiovascular Disease.
Braunwald E. NEJM May 26.
Click here
Principles of Immunosuppression in the Management of Kidney Disease: Core Curriculum 2022.
Kant S, et al. AJKD 2022 Apr 16.
Click here
The Drug-Induced Acute Kidney Injury.
Perazella MA et al. CJASN 2022 Mar 10.
Click here
The rational use of complement inhibitors in kidney diseases.
Fakhouri F, et al. KIRep. 2022 Mar 04.
Click here
Diuretics in States of Volume Overload: Core Curriculum 2022.
Novak JE, et al. AJKD 2022 Feb 18
Click here
Chlorthalidone for Hypertension in Advanced Chronic Kidney Disease.
Agarwal R, et al. NEJM. 2021 Dec 30.
Click here
High-dose intravenous iron reduces myocardial infarction in patients on haemodialysis.
Petrie MC, et al. Cardiovasc Res. 2021 Dec 07.
Click here
New Creatinine- and Cystatin C-Based Equations to Estimate GFR without Race.
Inker LA, et al. NEJM. 2021 Nov 4.
Click here
Chronic Kidney Disease-Associated Pruritus: A Review.
Makar M, et al. Kidney Blood Press Res. 2021 Sep 07.
Click here
Diagnosis and Management of Osteoporosis in Advanced Kidney Disease: A Review.
Ginsberg C, et al. AJKD. 2021 Aug 19.
Click here
The Risk of Acute Kidney Injury with Oral Anticoagulants in Elderly Adults with Atrial Fibrillation.
Harel Z, et al. CJASN 2021 Aug 18.
Click here
Principles of Kidney Pharmacotherapy for the Nephrologist: Core Curriculum 2021
Vondracek sF, et al. AJKD Jul 16
Click here
Risk of Potentially Inappropriate Medications in Adults With CKD: Findings From the Chronic Renal Insufficiency Cohort (CRIC) Study.
Hall RK et al. AJKD 2021 May.
Click here
A Clinician's Guide to Dosing Analgesics, Anticonvulsants, and Psychotropic Medications in Continuous Renal Replacement Therapy.
Bouajram RH, et al. KIRep. 2021 May.
Click here
International prescribing patterns and polypharmacy in older people with advanced chronic kidney disease: results from the European Quality study.
Hayward S, et al. NDT. 2021 Mar.
Click here
Post-Dialysis Parenteral Antimicrobial Therapy in Patients Receiving Intermittent High-Flux Hemodialysis.
Cimino C, et al. Drugs. 2021 Apr.
Click here
KDIGO 2021 Clinical Practice Guideline for the Management of Blood Pressure in Chronic Kidney Disease.
KDIGO Blood Pressure Work Group. Kidney Int. 2021 Mar.
Click here
Management of acute kidney injury in symptomatic multiple myeloma.
Bridoux F, et al. Kidney Int. 2021 Jan 09.
Click here
A Systematic Review and Meta-Analysis on Effects of Bicarbonate Therapy on Kidney Outcomes.
Hultin S, et al. KIRep. 2020 Dec 30.
Click here
A multi-center study on safety and efficacy of immune checkpoint inhibitors in cancer patients with kidney transplant.
Murakami N et al. Kidney Int. 2020 Dec 23.
Click here
Efficacy and safety of lowering LDL cholesterol in older patients: a systematic review and meta-analysis of randomised controlled trials.
Gencer B, et al. Lancet. 2020 Nov 21.
Click here
Comparison of different anticoagulation strategies for renal replacement therapy in critically ill patients with COVID-19: a cohort study.
Arnold F, et al. BMC Nephrol. 2020 Nov.
Click here
Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease.
Shavadia JS, et al. Am Heart J. 2020 Oct.
Click here
KDIGO Controversies Conference on onco-nephrology: understanding kidney impairment and solid-organ malignancies, and managing kidney cancer.
Porta C, et al. Kidney Int. 2020 Nov.
Click here
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.
Packer M, et al. NEJM. 2020 Oct 8.
Click here
Dapagliflozin in Patients with Chronic Kidney Disease.
Heerspink HJL, et al. NEJM 2020 Oct 08.
Click here
SGLT2 Inhibition for CKD and Cardiovascular Disease in Type 2 Diabetes: Report of a Scientific Workshop Sponsored by the National Kidney Foundation.
Tuttle KR, et al. AJKD. 2020 Oct.
Click here
KDIGO 2020 Clinical Practice Guideline for Diabetes Management in Chronic Kidney Disease.
KDIGO Diabetes Work Group. Kidney Int. 2020 Oct.
Click here
Treatment Options for COVID-19 in Patients with Reduced or Absent Kidney Function.
Miller-Handley H, Luckett K, Govil A. ACKD 2020 Sep 17.
Click here
Kidney, Cardiac, and Safety Outcomes Associated With α-Blockers in Patients With CKD: A Population-Based Cohort Study.
Hundemer GL, et al. AJKD 2020 Sep 11.
Click here
Medication Reconciliation: The Foundation of Medication Safety for Patients Requiring Dialysis.
Frament J, et al. AJKD. 2020 Sep 10.
Click here
Cystinuria: clinical practice recommendation.
Servais A, et al. Kidney Int. 2020 Sep 09.
Click here
Pathophysiology and Treatment of Enteric Hyperoxaluria.
Witting C, et al. CJASN 2020 Sep 08.
Click here
Pharmacological interventions for the prevention of renal injury in surgical patients: a systematic literature review and meta-analysis.
Pathak S, et al. BJA 2020 Aug 19.
Click here
The link between kidney disease and cancer: complications and treatment.
Malyszko J, et al. Lancet 2020 Jul 25.
Click here
Comparative Efficacy and Safety of BP-Lowering Pharmacotherapy in Patients Undergoing Maintenance Dialysis: A Network Meta-Analysis of Randomized, Controlled Trials.
Shaman AM, et al. CJASN 2020 Jul 18.
Click here
Adverse Drug Reactions in Patients with CKD.
Laville SM, et al. CJASN 2020 Jul 01.
Click here
Urate-Lowering Therapy and Chronic Kidney Disease Progression.
Feig DI. NEJM 2020 Jun 25.
Click here
Decision Algorithm for Prescribing SGLT2 Inhibitors and GLP-1 Receptor Agonists for Diabetic Kidney Disease.
Li J,et al. CJASN 2020 Jun 9.
Click here
NSAIDs in CKD: Are They Safe?
Baker M, et al. AJKD 2020 May 29.
Click here
How should I manage immunosuppression in a kidney transplant patient with COVID-19? An ERA-EDTA DESCARTES expert opinion.
Maggiore U, et al. NDT 2020 May 22.
Click here
Breastfeeding and Medication Use in Kidney Disease.
Singh M. ACKD. 2020 May 10.
Click here
Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers.
Danser AHJ, et al. Hypertension. 2020 Mar 25.
Click here
Proton Pump Inhibitors and the Kidney : Implications of Current Evidence for Clinical Practice and When and How to Deprescribe.
Al-Aly Z, et al. AJKD 2020 Apr.
Click here
Toxicology for Nephrologists.
Harbord N. ACKD. 2020 Jan.
Click here
Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment.
Batchelor EK, et al. JASN 2020 Feb.
Click here
Therapeutic management of HIV-infected patients with chronic kidney disease.
Alfano G, et al. J Nephrol. 2020 Feb.
Click here
Prevention and treatment of stroke in patients with chronic kidney disease: an overview of evidence and current guidelines.
Kelly DM, et al. Kidney Int. 2020 Feb.
Click here
The role of SGLT2 inhibitors in the management of chronic kidney disease. Metabolic and cardiorenal protective effects of SGLT2 inhibitors.
Heerspink HJL et al. NDT suppl. 2020 Jan
Click here
Medications Used Routinely in Primary Care to be Dose-Adjusted or Avoided in People With Chronic Kidney Disease: Results of a Modified Delphi Study.
Taji L, et al. Ann Pharmacother. 2020 Jan.
Click here
Clinical Characteristics of and Risk Factors for Chronic Kidney Disease Among Adults and Children: An Analysis of the CURE-CKD Registry.
Tuttle KR, et al. JAMA Netw Open. 2019 Dec.
Click here
Mineralocorticoid receptor antagonists in heart failure patients with chronic kidney disease: why, when, and how?
Kassem H, et al. Curr Opin Nephrol Hypertens 2019 Dec.
Click here
Kidney outcomes associated with use of SGLT2 inhibitors in real-world clinical practice (CVD-REAL 3): a multinational observational cohort study.
Heerspink HJL, et al. Lancet Diabetes Endocrinol. 2020 Jan.
Click here
Evolution of renal function under direct-acting antivirals treatment for chronic hepatitis C: A real-world experience.
Tsai MC, et al. J Viral Hepat. 2019 Dec.
Click here
Contraception and CKD.
Burgner A, et al. CJASN. 2019 Nov.
Click here
Acute kidney injury from sepsis: current concepts, epidemiology, pathophysiology, prevention and treatment.
Peerapornratana S,et al. Kidney Int. 2019 Nov.
Click here
Safe and Effective Management of Pain in People with CKD.
Davison SN, et al. CJASN 2019 Nov.
Click here
Comprehensive comparative effectiveness and safety of first-line antihypertensive drug classes: a systematic, multinational, large-scale analysis.
Suchard MA et al. Lancet. 2019 Oct 24.
Click here
SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis.
Neuen BL,et al. Lancet Diabetes Endocrinol. 2019 Nov.
Click here
Treatment for hepatorenal syndrome in people with decompensated liver cirrhosis: a network meta-analysis.
Best LM, et al. Cochrane Database Syst Rev. 2019 Sep.
Click here
Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C Virus Infection in Chronic Kidney Disease: Synopsis of the Kidney Disease: Improving Global Outcomes 2018 Clinical Practice Guideline.
Gordon CE,et al. Ann Intern Med. 2019 Sep.
Click here
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials.
Kristensen SL, et al. Lancet Diabetes Endocrinol. 2019 Oct.
Click here
Extracorporeal Removal of Poisons and Toxins.
King JD, et al. CJASN. 2019 Aug.
Click here
Sodium-Glucose Cotransporter-2 Inhibitors and the Risk for Severe Urinary Tract Infections: A Population-Based Cohort Study.
Dave CV, et al. Ann Intern Med. 2019 Jul.
Click here
Treatment-Related Adverse Events of PD-1 and PD-L1 Inhibitors in Clinical Trials: A Systematic Review and Meta-analysis.
Wang Y, et al. JAMA Oncol. 2019 Jul.
Click here
Benefits and Harms of Oral Anticoagulant Therapy in Chronic Kidney Disease: A Systematic Review and Meta-analysis.
Ha JT, et al. Ann Intern Med. 2019 Jul 16.
Click here
EASL Clinical Practice Guidelines: Drug-induced liver injury.
European Association for the Study of the Liver. J Hepatol. 2019 Jun.
Click here
Clinical Pharmacokinetics and Pharmacodynamics of Immune Checkpoint Inhibitors.
Centanni M, et al. Clin Pharmacokinet. 2019 Jul.
Click here
Sodium-glucose cotransporter inhibitors: beyond glycaemic control.
Vergara A, et al. CKJ 2019 Jun.
Click here
Anticoagulant-related nephropathy: systematic review and meta-analysis.
de Aquino Moura KB, et al. CKJ 2019 Jun.
Click here
Rituximab or Cyclosporine in the Treatment of Membranous Nephropathy.
Fervenza FC, et al. NEJM 2019 Jul 4.
Click here
Direct-acting antiviral therapy slows kidney function decline in patients with Hepatitis C virus infection and chronic kidney disease
Sise ME, et al. Kidney Int. 2019 May 15.
Click here
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Perkovic V, et al. NEJM. 2019 Jun 13.
Click here
Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE-TIMI 58 randomised trial.
Mosenzon O, et al. Lancet Diabetes Endocrinol. 2019 Jun.
Click here
Efficacy and Safety of Evolocumab in Chronic Kidney Disease in the FOURIER Trial.
Charytan DM, et al. JACC 2019 Jun.
Click here
Heart failure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
House AA, et al. Kidney Int. 2019 Jun.
Click here
Contrast-Associated Acute Kidney Injury.
Mehran R, et al. NEJM 2019 May 30.
Click here
Atorvastatin Has a Dose-Dependent Beneficial Effect on Kidney Function and Associated Cardiovascular Outcomes: Post Hoc Analysis of 6 Double-Blind Randomized Controlled Trials.
Vogt L, et al. JAHA 2019 May.
Click here
Comparative Cardiac Safety of Selective Serotonin Reuptake Inhibitors among Individuals Receiving Maintenance Hemodialysis.
Assimon MM, et al. JASN 2019 Apr.
Click here
Blood pressure in chronic kidney disease: conclusions from a Kidney Disease Improving Global Outcomes (KDIGO) Controversies Conference.
Cheung AK, et al. for Conference Participants. Kidney Int. 2019 May.
Click here
β blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial.
Villanueva C, et al. Lancet. 2019 Apr 20.
Click here
New pharmacological strategies for protecting kidney function in type 2 diabetes.
Muskiet MHA, et al. Lancet Diabetes Endocrinol. 2019 May.
Click here
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
Perkovic V, et al. for the CREDENCE Trial Investigators. NEJM 2019 Apr 14.
Click here
Clinical Pharmacology in Diuretic Use.
Ellison DH. CJASN 2019 Apr 1.
Click here
Dose recommendations for anticancer drugs in patients with renal or hepatic impairment.
Krens SD, et al. Lancet Oncol. 2019 Apr.
Click here
The safety of mineralocorticoid antagonists in maintenance hemodialysis patients: two steps forward.
Rossignol P, et al. Kidney Int. 2019 Apr.
Click here
Management of Hypertension in Chronic Kidney Disease.
Dan Pugh, et al. Drugs 2019 Mar.
Click here
Combination Therapy as First-Line Treatment in Metastatic Renal-Cell Carcinoma.
Escudier B. NEJM 2019 Mar 21.
Click here
Antibiotic Dosing in Chronic Kidney Disease and End-Stage Renal Disease: A Focus on Contemporary Challenges.
Vilay AM. ACKD. 2019 Jan.
Click here
Clinical Pharmacology of Antibiotics.
Eyler RF, et al. CJASN March 2019.
Click here
Clinical Pharmacology Considerations in Pain Management in Patients with Advanced Kidney Failure.
Davison SN. Clin J Am Soc Nephrol. 2019 Mar 4.
Click here
Special Issue:Hepatitis C Virus Infection in Patients with Kidney Disease: A Roadmap for Nephrologists.
Semin Dial. 2019 Mar/Apr;32(2):89-197.
Click here
Pharmacological treatments for generalised anxiety disorder: a systematic review and network meta-analysis.
Slee A, Nazareth I, Bondaronek P, Liu Y, Cheng Z, Freemantle N. Lancet. 2019 Feb 23;3(10173):768-77.
Click here
Therapeutic Inhibition of VEGF Signaling and Associated Nephrotoxicities.
Estrada CC, Maldonado A, Mallipattu SK. J Am Soc Nephrol. 2019 Feb;30(2):187-200.
Click here
Once-Daily Plazomicin for Complicated Urinary Tract Infections.
Wagenlehner FME, Cloutier DJ, Komirenko AS, Cebrik DS, Krause KM, Keepers TR, Connolly LE, Miller LG, Friedland I, Dwyer JP; EPIC Study Group. N Engl J Med. 2019 Feb 21;380(8):729-740.
Click here
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by the EURECA-m and the DIABESITY working groups of the ERA-EDTA.
Sarafidis P, et al. Nephrol Dial Transplant. 2019 Feb 1;34(2):208-230.
Click here
14/03/2024 : Pharmacologie des médicaments et fenêtre thérapeutique
Click here
14/03/2024 : Les intoxications médicamenteuses vues aux urgences : les petites nouvelles
Click here
14/03/2024 : Reins & Médicaments toxiques
Click here
23/11/2023 : La juste prescription pour l’insuffisance rénale et la dialyse. Un outil indispensable : RenAdaptor.
Click here
15/06/2023 : Bénéfices des anti diabétiques au niveau cardio-vasculaire en 2023
Click here
15/06/2023 : Prise en charge multi-cible du patient diabétique : de la théorie à la pratique
Click here
05/06/2023 : La juste prescription pour l'insuffisance rénale et la dialyse: RenAdaptor.
Click here
09/03/2023 : Place de la pharmacie clinique pour réduire les erreurs de prescription en milieu hospitalier.
Click here
09/03/2023 : Polymédication et erreurs de prescription en gériatrie : comment y remédier ?
Click here
09/03/2023 : Fonds des Accidents Médicaux : Sinistres liés à des erreurs de prescription.
Click here
10/11/2022 : La révolution des gliflozines en néphrologie.
Click here
10/11/2022 : Règles de bases de néphroprotection en 2022.
Click here
16/06/2022 : SGLT2i ou la révolution néphrologique du XXIème siècle ?
Click here
16/06/2022 : Traiter le diabète de type 2 et réduire le risque cardio-vasculaire et rénal: mode d'emploi en 2022
Click here
16/06/2022 : La révolution des Inhibiteurs du SGLT2 pour les patients cardiaques
Click here
28/04/2022 : Two medications I would actively stop in elderly patients
Click here
10/03/2022 : Mesure et estimation du DFG pour un usage clinique en 2022
Click here
10/03/2022 : Impact de la bonne évaluation du DFG sur la prescription des médicaments.
Click here
10/03/2022 : Adaptation posologique lors d'une insuffisance rénale : Les cas du diabète et du cancer.
Click here
21/09/2021 : iSGLT2 et reins
Click here
16/03/2021 : Reins et sénescence
Click here
23/03/2020 : COVID-19, Plaquenil et Insuffisance rénale
Click here
12/12/2019 : La juste prescription pour l'insuffisance rénale et la dialyse : Renadaptor
Click here
14/03/2019 : IPP et reins font-ils bon ménage ?
Click here
14/03/2019 : Hepatitis C Virus Infection in Patients with Chronic Kidney Disease
Click here
14/03/2019 : L'axe Reins - Microbiote
Click here
06/12/2018 : La grippe en 2018 - 2019
Dr. Benoit Pirotte
Click here
Dr. Filip Moerman
Click here
01/12/2018 : Nouveautés diagnostiques et thérapeutiques en néphrologie : Une décennie riche en avancées.
Click here
21/06/2018 : Propriétés néphroprotectrices des nouveaux anti-dabétiques oraux (ADO)
Click here
02/06/2018 : Anticoagulation et Insuffisance Rénale
Click here
18/04/2018 : Traitements de l'ostéoporose chez l'insuffisant rénal chronique.
Click here
08/03/2018 : Particularités pharmacologiques de la personne âgée
Click here
08/03/2018 : Cibles Cardio-Vasculaires chez les plus de 75 ans.
Click here
08/03/2018 : Polymédication chez la personne âgée
Click here
12/12/2017 : Polykystose Rénale Autosomique Dominante (PKRAD): Avancées thérapeutiques récentes
Click here
04/12/2017 : La prise en charge des patients séropositifs pour le VIH en 2017
Click here
25/11/2017 : Diagnostic et prévention de la lithiase rénale récidivante
Click here
09/03/2017 : Approche thérapeutique en oncologie: Le point de vue de l'oncologue.
Click here
09/03/2017 : Mélanome métastatique - Thérapies ciblées / Immunothérapies
Click here
09/03/2017 : Ajustement des traitements anticancéreux à l'insuffisance rénale - L'importance d'être précis
Click here
09/03/2017 : Toxicité rénale des traitements en oncologie: Focus sur les nouvelles thérapies
Click here
